Optiray 350
Generic name: Ioversol
Drug class:
Non-ionic iodinated contrast media
Usage of Optiray 350
Optiray 350 is a radiopaque contrast agent. This medicine contains iodine, a substance that absorbs x-rays. Contrast agents are used to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic (x-ray) examination.
Optiray 350 is used to help diagnose certain disorders of the heart, brain, and blood vessels.
Optiray 350 may also be used for purposes not listed in this medication guide.
Optiray 350 side effects
Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling).
Seek medical treatment if you have a serious drug reaction that can affect many parts of your body. Symptoms may include: skin rash, fever, swollen glands, flu-like symptoms, muscle aches, severe weakness, unusual bruising, or yellowing of your skin or eyes.
Some of the side effects of ioversol can occur up to 24 hours after you receive the medication.
Tell your caregivers or call your doctor at once if you have:
Side effects may be more likely in older adults.
Common side effect may include nausea.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Optiray 350
You should not be treated with Optiray 350 if you are allergic to it, or if you have:
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant.
You should not breastfeed within 8 hours after receiving Optiray 350. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby.
Relate drugs
- Iodixanol
- Iohexol (Injection, Intrathecal, Intravenous)
- Iohexol (Oral)
- Iopamidol
- Iopromide
- Ioversol
- Isovue-200
- Isovue-250
- Isovue-300
- Isovue-370
- Isovue-M-200
- Isovue-M-300
- Omnipaque 12
- Omnipaque 140
- Omnipaque 180
- Omnipaque 240
- Omnipaque 300
- Omnipaque 350
- Omnipaque 9
- Omnipaque Flexipak
- Optiray 160
- Optiray 240
- Optiray 300
- Optiray 320
- Optiray 350
- Oraltag
- Ultravist
- Visipaque
How to use Optiray 350
Optiray 350 is given as an infusion into a vein or artery. A healthcare provider will give you this injection.
Drink extra fluids before and after your radiologic test. Optiray 350 can cause you to get dehydrated, which can lead to dangerous effects on your kidneys. Follow your doctor's instructions about the types and amount of fluids you should drink before and after your test.
Older adults may need special care to avoid becoming dehydrated. Your kidney function may need to be checked after you have received Optiray 350.
Children younger than 3 years may need to have their thyroid function checked after exposure to Optiray 350. Talk with your doctor if you have any questions.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Optiray 350 is injected.
Some people receiving Optiray 350 have had delayed reactions 30 to 60 minutes after injection. Your caregivers will watch you during this time to make sure you do not have unwanted side effects or delayed reactions.
Optiray 350 can cause unusual results with certain medical tests for up to 16 days after you receive Optiray 350. For up to 8 weeks after you receive this medicine, your body may not respond as well as usual to radioactive iodine thyroid treatment. Tell any doctor who treats you that you have recently received this medicine.
Warnings
You should not be treated with Optiray 350 if you have symptoms of an overactive thyroid. Tell your doctor if you have ever had any type of reaction to another contrast agent.
What other drugs will affect Optiray 350
Tell your doctor about all your current medicines, especially:
This list is not complete. Other drugs may affect Optiray 350, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions